Karyopharm Therapeutics Inc (KPTI) insider trading
Every open-market stock purchase and sale by Karyopharm Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $348K over the last 12 months (17 sales). No open-market buys.
- Last insider buy: Garen G Bohlin (Insider), $50K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $348K (17 sales). Last close $9.08 on Jun 4, 2026.
Recent KPTI insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 21, 2026 | Zhen Su (Insider) | Bought (not open market) | — |
| May 21, 2026 | Deepika Pakianathan (Insider) | Bought (not open market) | — |
| May 21, 2026 | Barry E Greene (Insider) | Bought (not open market) | — |
| May 21, 2026 | Chen Schor (Insider) | Bought (not open market) | — |
| May 21, 2026 | Christy J. Oliger (Insider) | Bought (not open market) | — |
| May 21, 2026 | Garen G Bohlin (Insider) | Bought (not open market) | — |
| May 14, 2026 | Richard A. Paulson (CEO) | Sold | $20.9K |
| May 14, 2026 | Reshma Rangwala (C-suite exec) | Sold | $3.9K |
| May 14, 2026 | Stuart Poulton (C-suite exec) | Sold | $3.8K |
| May 14, 2026 | Sohanya Roshan Cheng (C-suite exec) | Sold | $3.1K |
| May 14, 2026 | Michael Mano (C-suite exec) | Sold | $2.5K |
| May 14, 2026 | Kristin Abate (C-suite exec) | Sold | $504 |
| May 13, 2026 | Sohanya Roshan Cheng (C-suite exec) | Bought (not open market) | — |
| May 13, 2026 | Reshma Rangwala (C-suite exec) | Bought (not open market) | — |
| May 13, 2026 | Kristin Abate (C-suite exec) | Bought (not open market) | — |
| May 13, 2026 | Michael Mano (C-suite exec) | Bought (not open market) | — |
| May 13, 2026 | Richard A. Paulson (CEO) | Bought (not open market) | — |
| May 13, 2026 | Stuart Poulton (C-suite exec) | Bought (not open market) | — |
| Apr 21, 2026 | Reshma Rangwala (C-suite exec) | Sold | $4K |
| Mar 2, 2026 | Richard A. Paulson (CEO) | Sold | $116K |
| Mar 2, 2026 | Stuart Poulton (C-suite exec) | Sold | $48K |
| Mar 2, 2026 | Reshma Rangwala (C-suite exec) | Sold | $47.7K |
| Mar 2, 2026 | Sohanya Roshan Cheng (C-suite exec) | Sold | $43.3K |
| Mar 2, 2026 | Michael Mano (C-suite exec) | Sold | $33.2K |
| Mar 2, 2026 | Kristin Abate (C-suite exec) | Sold | $5.3K |
Who's trading KPTI
- Chen Schor, Insider: other filings, last May 21, 2026
- Deepika Pakianathan, Insider: other filings, last May 21, 2026
- Christy J. Oliger, Insider: other filings, last May 21, 2026
- Barry E Greene, Insider: other filings, last May 21, 2026
- Zhen Su, Insider: other filings, last May 21, 2026
- Garen G Bohlin, Insider: other filings, last May 21, 2026
- Kristin Abate, C-suite exec: sold $7.7K (4 sales), last May 14, 2026
- Sohanya Roshan Cheng, C-suite exec: sold $46.4K (2 sales), last May 14, 2026
- Michael Mano, VP: sold $35.7K (2 sales), last May 14, 2026
- Richard A. Paulson, CEO: sold $137K (2 sales), last May 14, 2026
- Stuart Poulton, C-suite exec: sold $55.1K (3 sales), last May 14, 2026
- Reshma Rangwala, C-suite exec: sold $55.6K (3 sales), last May 14, 2026
- Lori Macomber, CFO: sold $10.2K (1 sale), last Feb 3, 2026
Get free alerts when an insider at Karyopharm Therapeutics Inc files a new trade →